Lung Cancer in Morocco

Area of Science:

• Oncology
• Public Health
• Health Services Research

Background:

• Morocco experiences a significant disparity between global thoracic oncology standards and its healthcare system's capabilities.
• Key challenges include inadequate diagnostics, inconsistent molecular testing access, and high patient costs.

Purpose of the Study:

• To comprehensively analyze the lung cancer care pathway in Morocco.
• To identify systemic barriers and evaluate recent health policy reforms impacting cancer care.

Main Methods:

• Synthesis of clinical experience and service-level data.
• In-depth policy analysis of Moroccan healthcare reforms.
• Mapping the continuum of lung cancer care from diagnosis to survivorship.

Main Results:

• Limited infrastructure for advanced diagnostics (biopsy, pathology, next-generation sequencing) and treatment (radiotherapy, surgery).
• Fragmented access to molecular testing, targeted therapies, and survivorship care.
• Recent policy initiatives show promise but face operational hurdles impacting widespread benefit.

Conclusions:

• Significant gaps persist in Morocco's lung cancer care continuum, despite policy advancements.
• Addressing diagnostic, therapeutic, and supportive care fragmentation is crucial for improving patient outcomes.